from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3764c/tcrY

LFCtreatmentdescriptionclass of inhibitor

-0.261

Amikacinug/mL Amikacintranslation

0.334

Cap5-10ug/mL Capreomycintranslation

0.056

Rox10-50 ug/mL Roxithromycintranslation

-0.578

SM2-5 ug/mL Streptomycintranslation

-0.166

Tet5-10 ug/mL Tetracyclinetranslation

-0.221

Rif0.2-5ug/mL Rifampicintranscription

0.047

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.319

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.518

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.878

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.395

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.175

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.498

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.727

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.374

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.346

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.323

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.208

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.757

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.194

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.376

KCN5-20 ug/mL Potassium cyaniderespiration

-1.069

NaN30.2-2 mM Sodium aziderespiration

0.492

Nigericin50 uM Nigericinrespiration

-0.570

TRC10-150 ug/mL Triclosanrespiration

1.396

TRZ10-25 ug/mL Thioridazinerespiration

1.923

Valinomycin0.5-10 uM Valinomycinrespiration

1.431

ZnSO42 mM ZnSO4respiration

-0.024

menadione6-10 ug/mL Menadionerespiration

-0.154

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.136

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.574

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.196

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.068

NRP_1Non-replicating persistence stage 1dosRassociated

-0.191

Amp0.2mg/mL AmpicillincellWall

-0.328

Cephalexin20-100 ug/mL CephalexincellWall

-0.566

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.662

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.237

EMB10-20 ug/mL EthambutolcellWall

-0.010

Eta12-40 ug/mL EthionamidecellWall

-0.526

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.284

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.335

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.222

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.401

BZA0.12 mg/mL BenzamidearomaticAmides

-0.332

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.273

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.281

H2O24 mM hydrogen peroxideDNAdamaging

0.227

Levo10 ug/mL LevofloxacinDNAdamaging

0.139

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.353

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.248

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.150

UVUV-irradiationDNAdamaging

0.859

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.291

Antimycin12.5-50 ug/mL Antimycin A?

0.508

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.692

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.833

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.636

PA8240.2-2 ug/mL PA-824?

0.194

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.053

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.568

Verapamil50 uM Verapamil?

0.499

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.639

methoxatin10-20 ug/mL Methoxatin?